Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP92189.RAcaW7sJHUYbehNJXJpuPBr_E7Rno65xxxn5sYplxvx4g130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92189.RAcaW7sJHUYbehNJXJpuPBr_E7Rno65xxxn5sYplxvx4g130_provenance.
• NP106972.RAQlWl9yVnynnAuVEcpWheNX0GxxV-YdmtrBIRBdvqktw130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106972.RAQlWl9yVnynnAuVEcpWheNX0GxxV-YdmtrBIRBdvqktw130_provenance.
• NP111452.RAWNsm_H4FsXey65Gc5ErgUo7SkxmVGKfwSHKbdWeK7aA130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111452.RAWNsm_H4FsXey65Gc5ErgUo7SkxmVGKfwSHKbdWeK7aA130_provenance.
• assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP106974.RAnnlmia_ln6Dps0VGtOWcEhJZkwgBsEeYfR36ci-gPMA130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106974.RAnnlmia_ln6Dps0VGtOWcEhJZkwgBsEeYfR36ci-gPMA130_provenance.
• NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149385.RAX7plnm5kMh3RP4BvvIxi5Sn948LuyoaXkLGbnSfB9s0130_provenance.
• NP149387.RAQLOKi9Myrt7MPB875Qk5-sS7IfdBU7_q2DEWkjXPhPQ130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149387.RAQLOKi9Myrt7MPB875Qk5-sS7IfdBU7_q2DEWkjXPhPQ130_provenance.
• assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP92188.RANpjA7E4SEIWLL-jo7cgFKLVOtpcqDpMUbwlMi5rA6CQ130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92188.RANpjA7E4SEIWLL-jo7cgFKLVOtpcqDpMUbwlMi5rA6CQ130_provenance.
• NP111453.RAJzd6xA3qQIyaQcTH0a_7k-2AgzRIYl_6uADSkcbAR8Y130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111453.RAJzd6xA3qQIyaQcTH0a_7k-2AgzRIYl_6uADSkcbAR8Y130_provenance.
• NP149386.RAOFP-P1cSP4bamLfL-MZovErZC23K2XYiyQXGaF3AIgM130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149386.RAOFP-P1cSP4bamLfL-MZovErZC23K2XYiyQXGaF3AIgM130_provenance.
• NP149389.RAOWXqOwhFFFj8za0jgAKx_D1eRdCKLu9TMqvA6Fjd7uQ130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149389.RAOWXqOwhFFFj8za0jgAKx_D1eRdCKLu9TMqvA6Fjd7uQ130_provenance.
• NP149384.RA8h7QNx9-yrR5KVkUnvltBH-xcKUwJ8LbVzZnTi-6QPQ130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149384.RA8h7QNx9-yrR5KVkUnvltBH-xcKUwJ8LbVzZnTi-6QPQ130_provenance.
• NP149388.RAyZfJ92oB8dA3CoSIl8RvBfvlS6X2iM8JF1sdaXJAlJI130_assertion description "[Erlotinib treatment may present criteria justifying dose individualisation but further studies, including more patients, are necessary to define the modalities of this adaptation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149388.RAyZfJ92oB8dA3CoSIl8RvBfvlS6X2iM8JF1sdaXJAlJI130_provenance.